Press Releases

Edinburgh, UK – 1st of June 2023: Manus Neurodynamica Limited (“Manus”), which develops and markets products and technologies for neuromotor assessment, announces it has expanded its Senior Management team with the appointments of VP of Sales, Roberto Marcucci, Chief Technology Officer, Dr David Bramwell, Chief Financial Officer, Phil Pattison and Chairman, Albert Nicholl. Roberto Marcucci, … Read more

Prevention Suite platform used by more than 10,000 pharmacies in Italy, Spain and Portugal. Partnership to be showcased at the annual Cosmofarma Exhibition in Bologna, Italy this weekend Edinburgh, UK – 5 May 2023: Manus Neurodynamica Limited (“Manus”), which develops and markets products and technologies for neuromotor assessment, announces it has signed an agreement with … Read more

Manus named awardee in ‘Improving Detection of Neurotoxicity in Immunotherapies’ QuickFire Challenge Edinburgh, UK – 24 April 2023: Manus Neurodynamica Limited (“Manus”), which develops and markets products and technologies for neuromotor assessment, announces that it has been named an awardee in the ‘Improving Detection of Neurotoxicity in Immunotherapies’ QuickFire Challenge managed by Johnson & Johnson … Read more

Appointment of Dr Guy Wood-Gush to the Board of Directors, and hires of Senior Data Scientist and Technical Operations and Project Manager Edinburgh, UK – 21 December 2021: Manus Neurodynamica Limited (“Manus”), which develops and markets products and technologies for neuromotor assessment, announces the appointment of Dr Guy Wood-Gush as a Non-Executive Director of the … Read more

Designation provides priority regulatory review of the Manus NeuroMotor Pen™ designed to aid the diagnoses of Parkinson’s Disease Manus Neurodynamica Limited (“Manus”), which develops and markets products and technologies for neuromotor assessment, announces that it has been granted Breakthrough Designation by the U.S. Food and Drug Administration (“FDA”) for its Neuro-Motor PenTM (“NMP”) device. Breakthrough … Read more